RAD - Rite Aid Corporation

NYSE - NYSE Delayed Price. Currency in USD
1.07
-0.01 (-0.93%)
At close: 4:00PM EDT

1.06 -0.01 (-0.93%)
Pre-Market: 8:07AM EDT

Stock chart is not supported by your current browser
Previous Close1.08
Open1.07
Bid1.06 x 1000
Ask1.07 x 306100
Day's Range1.07 - 1.09
52 Week Range1.02 - 2.55
Volume7,352,911
Avg. Volume14,887,521
Market Cap1.127B
Beta (3Y Monthly)1.79
PE Ratio (TTM)1.60
EPS (TTM)0.67
Earnings DateSep 20, 2017 - Sep 25, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1999-10-14
1y Target Est1.31
Trade prices are not sourced from all markets
  • Walgreens wants to be seen as a health-care company, not just a retailer
    CNBC2 days ago

    Walgreens wants to be seen as a health-care company, not just a retailer

    It's not that being a retailer is a bad thing. But investors want drugstores to reinvent their businesses as Amazon already steals sales of everyday items like toilet paper and will soon enter the prescription drug delivery business with its acquisition of online pharmacy, Pillpack.

  • Business Wire2 days ago

    Rite Aid Offering Free Advisor Tool to Help Medicare Beneficiaries Choose Prescription Drug Coverage for 2019

    As the annual Medicare Part D election period gets underway, from now through Dec. 7, 2018, Medicare-eligible customers can visit Rite Aid pharmacies nationwide to take advantage of free resources that help them select the right prescription drug plan or update existing coverage for 2019.

  • CVS Health CEO Larry Merlo doesn't want to leave any 'white space' for Amazon to disrupt
    CNBC3 days ago

    CVS Health CEO Larry Merlo doesn't want to leave any 'white space' for Amazon to disrupt

    CVS is trying to become a disruptive force itself with its roughly $69 billion acquisition of health insurer Aetna.

  • How Investors Reacted to Walgreens’s Fourth-Quarter Results
    Market Realist3 days ago

    How Investors Reacted to Walgreens’s Fourth-Quarter Results

    As we’ve already seen in this series, Walgreens Boots Alliance (WBA) posted better-than-expected fourth quarter of fiscal 2018 earnings yesterday but missed the top-line projections.

  • Walgreens: Key Revenue Drivers in Fourth Quarter of Fiscal 2018
    Market Realist6 days ago

    Walgreens: Key Revenue Drivers in Fourth Quarter of Fiscal 2018

    As we’ve already seen in this series, Walgreens Boots Alliance’s (WBA) fourth quarter of fiscal 2018 sales increased 11% YoY (year-over-year) to $33.4 billion. As in the previous quarters, growth was driven by a strong performance of its Retail Pharmacy USA division.

  • Prescription Volume Boosts Walgreens’s Top Line in Fiscal 2018
    Market Realist6 days ago

    Prescription Volume Boosts Walgreens’s Top Line in Fiscal 2018

    Walgreens Boots Alliance (WBA) reported its fourth quarter of fiscal 2018 results yesterday. Organic sales rose 3.2%. Behind the miss was a fall in sales of personal care products and over-the-counter drugs.

  • ACCESSWIRE6 days ago

    Today’s Research Reports on Stocks to Watch: Rite Aid and Walgreens

    Shares of Rite Aid were trailing and closed down over 6% despite the company not having any news. Walgreens Boots Alliance, Inc. shares were down nearly 2% on Thursday on about 14.5 million shares traded. Walgreens reported adjusted earnings per share (EPS) of $1.48, beating street’s estimate of $1.45.

  • Walgreens Boots Alliance, Inc. (WBA) Q4 2018 Earnings Conference Call Transcript
    Motley Fool7 days ago

    Walgreens Boots Alliance, Inc. (WBA) Q4 2018 Earnings Conference Call Transcript

    WBA earnings call for the period ending August 31, 2018.

  • Walgreens Stock Rises as RBC Increases Price Target 20%
    Market Realist9 days ago

    Walgreens Stock Rises as RBC Increases Price Target 20%

    RBC Capital Markets raised the price target for drugstore chain Walgreens Boots Alliance (WBA) from $68 to $82 (or ~20%) on Monday, October 8. Analyst George Hill maintained an “outperform” recommendation for the company and said Walgreens was one of the best-positioned companies in the retail pharmacy space. Although Hill is still concerned about Walgreens’s pricing in the United States, he expects some improvement in the Medicare Part D preferred pharmacy network business next year.

  • Wall Street Doesn’t Expect Walgreens Stock to Rise Further
    Market Realist10 days ago

    Wall Street Doesn’t Expect Walgreens Stock to Rise Further

    Walgreens stock has witnessed a high level of volatility over the past year. Its price has moved between $59.07 and $80.68 over the last 52 weeks.

  • Did Rite Aid Stock Just Hit Rock Bottom?
    Motley Fool10 days ago

    Did Rite Aid Stock Just Hit Rock Bottom?

    The drugstore operator's stock has closed at the exact same price for the last four consecutive days. Let's fix the clock broken at a $1.15 close.

  • Here’s How Walgreens Stock Has Performed So Far in 2018
    Market Realist10 days ago

    Here’s How Walgreens Stock Has Performed So Far in 2018

    After being battered in the stock market during the first six months of 2018, Walgreens Boots Alliance (WBA) has finally bounced back. Shares of WBA were down ~18% as of June 28, when the company reported its fiscal 2018 third-quarter results. It was instead the result of fears about Amazon expanding its footprint in the pharmacy retail space.

  • Walgreens’s EPS to Rise 11% in Q4 2018
    Market Realist13 days ago

    Walgreens’s EPS to Rise 11% in Q4 2018

    Wall Street expects a 10.7% YoY (year-over-year) jump in Walgreens Boots Alliance’s (WBA) EPS to $1.45 during the fourth quarter of fiscal 2018. The pharmacy giant hasn’t missed analysts’ earnings expectations for the last 16 consecutive quarters.

  • Walgreens Is Set to Report Its Q4 2018 Results Next Week
    Market Realist13 days ago

    Walgreens Is Set to Report Its Q4 2018 Results Next Week

    Walgreens Boots Alliance: A Q4 2018 Earnings PreviewWBA is ready to report its fourth-quarter results

  • Business Wire15 days ago

    Rite Aid Applauds Passage of Legislation Helping Seniors Access Pharmacy Services to Prevent Opioid Abuse

    ‘SUPPORT for Patients and Communities Act’ expands eligibility for Medicare Part D seniors to receive Medication Therapy Management counseling services from pharmacists

  • Is the Options Market Predicting a Spike in Rite Aid (RAD) Stock?
    Zacks15 days ago

    Is the Options Market Predicting a Spike in Rite Aid (RAD) Stock?

    Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.

  • Business Wire16 days ago

    From Halloween to Harvest, Rite Aid Has All of Fall Covered

    This year, Rite Aid has all of fall covered with a spirited selection of Halloween and harvest essentials like candy, costumes, décor and more. To celebrate the spookiest of seasons, wellness+ rewards BonusCash is transforming into “Boo-nus Cash” to offer scary-good savings all season long through Rite Aid’s customer loyalty program. From chocolate and fruity to sweet and sour, Rite Aid has a treat for every taste, whether you’re stocking up for trick-or-treat, planning a Halloween bash or looking to impress the neighbors with full-sized candy bars.

  • Business Wire16 days ago

    Rite Aid Honoring its Pharmacy Champions During American Pharmacists Month

    Customers can win $2,500 in Rite Aid Gift Cards by Recognizing Rite Aid Pharmacists, Pharmacy Technicians and Wellness Ambassadors for Outstanding Service and Care

  • Rite Aid Reports in-Line EPS in the Second Quarter
    Market Realist20 days ago

    Rite Aid Reports in-Line EPS in the Second Quarter

    Rite Aid (RAD) reported a second-quarter adjusted net loss from continuing operations of $7.9 million or $0.01 loss per share. This loss compares to an adjusted net loss of $17.4 million or $0.02 per share in the corresponding quarter last year. The company delivered in line with Wall Street’s expectations for the quarter.

  • What Drove Down Rite Aid’s Second-Quarter Top Line?
    Market Realist20 days ago

    What Drove Down Rite Aid’s Second-Quarter Top Line?

    As we outlined in the previous part of this series, Rite Aid (RAD) reported a 1.4% YoY (year-over-year) increase in revenues from continuing operations to $5.42 billion during the second quarter of 2019, which ended on September 1. The company’s Retail Pharmacy segment—under which it sells prescription drugs, health and beauty products, personal care items, et cetera—recorded a 0.2% increase in sales during the quarter. Sales comps from continuing operations increased 1% YoY, driven by a 1.6% increase in pharmacy sales and a 0.1% fall in front-end sales.

  • Rite Aid Finally Posts Top-Line Growth in the Second Quarter
    Market Realist20 days ago

    Rite Aid Finally Posts Top-Line Growth in the Second Quarter

    Rite Aid (RAD) reported results for the second quarter—which ended on September 1—yesterday. The company’s top line from continuing operations improved 1.4 % YoY (year-over-year) to $5.42 billion. Wall Street, in comparison, had projected a 0.3% YoY increase in sales to $5.36 billion.

  • How Rite Aid Performed in the Second Quarter
    Market Realist20 days ago

    How Rite Aid Performed in the Second Quarter

    Rite Aid (RAD) reported its results for the second quarter, which ended on September 1, before the bell yesterday. See the next three parts of this series to learn more about the company’s top- and bottom-line performance. It has also decided to separate the positions of chairman and CEO.

  • ACCESSWIRE20 days ago

    Today’s Research Reports on Stocks to Watch: Rite Aid and Conagra Brands

    NEW YORK, NY / ACCESSWIRE / September 28, 2018 / Both Conagra Brands and Rite Aid plummeted during Thursday's session after reporting financial results. Rite Aid also announced some executive changes. ...

  • Rite Aid Reports In-Line Fiscal Q2 2019 Earnings, Shakes Up Board
    Market Realist21 days ago

    Rite Aid Reports In-Line Fiscal Q2 2019 Earnings, Shakes Up Board

    Rite Aid (RAD) reported its results for the second quarter of fiscal 2019 before this morning’s bell. Rite Aid’s total sales increased 1.4% YoY (year-over-year) to $5.4 billion from continuing operations, beating Thomson Reuters’ I/B/E/S estimates by $60.0 million. “During the quarter, we have been hard at work accelerating our standalone strategy to capitalize on key opportunities to grow our business,” said John Standley, Rite Aid’s chairman and CEO.

  • The Wall Street Journal21 days ago

    [$$] Rite Aid Shakes Up Board, Reports Higher Revenue

    Aid Corp. will make changes to its board after its merger deal with grocery chain Albertson’s unraveled last month. The Camp Hill, Pa.-based company will separate the positions of chairman and chief executive, Rite Aid announced Thursday. John Standley received total compensation of $9.32 million for fiscal 2018, ended March 3, according to a regulatory filing made Thursday.